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Abstract
Background: Periodontitis and Alzheimer disease (AD) are associated with
systemic inflammation. This research studied serum IgG to periodontal microbiota
as possible predictors of incident AD.
Methods: Using a case-cohort study design, 219 subjects (110 incident AD cases
and 109 controls without incident cognitive impairment at last follow-up), matched
on race-ethnicity, were drawn from the Washington Heights-Inwood Columbia
Aging Project (WHICAP), a cohort of longitudinally followed northern Manhattan
residents aged .65 years. Mean follow-up was five years (SD 2.6). In baseline
sera, serum IgG levels were determined for bacteria known to be positively or
negatively associated with periodontitis (Porphyromonas gingivalis, Tannerella
forsythia, Actinobacillus actinomycetemcomitans Y4, Treponema denticola,
Campylobacter rectus, Eubacterium nodatum, and Actinomyces naeslundii
genospecies-2). In all analyses, we used antibody threshold levels shown to
correlate with presence of moderate-severe periodontitis.
Results: Mean age was 72 years (SD 6.9) for controls, and 79 years (SD 4.6) for
cases (p,0.001). Non-Hispanic Whites comprised 26%, non-Hispanic Blacks 27%,
and Hispanics 48% of the sample. In a model adjusting for baseline age, sex,
education, diabetes mellitus, hypertension, smoking, prior history of stroke, and
apolipoprotein E genotype, high anti-A. naeslundii titer (.640 ng/ml, present in
10% of subjects) was associated with increased risk of AD (HR52.0, 95%CI: 1.1–
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3.8). This association was stronger after adjusting for other significant titers
(HR53.1, 95%CI: 1.5–6.4). In this model, high anti-E. nodatum IgG (.1755 ng/ml;
19% of subjects) was associated with lower risk of AD (HR50.5, 95%CI: 0.2–0.9).
Conclusions: Serum IgG levels to common periodontal microbiota are associated
with risk for developing incident AD.
Introduction
Poor oral health, including caries, periodontal disease, and edentulism are highly
prevalent globally, particularly in the elderly. [1] Caries and periodontitis share
common risk factors, including infectious etiologies, and are main contributors to
tooth loss in elderly populations. [2] Periodontitis prevalence estimates among
adults vary widely (20%–.80%), [1, 3] and this variability is partly attributed to
varying disease definitions. [4]
Periodontitis is a chronic inflammatory disease, initiated by a bacterial biofilm
adhering to the tooth surfaces adjacent to the gingiva. [5, 6] Oral colonization by
periodontal bacterial pathogens6 is ubiquitous in older adults, [7] with a
significant proportion of the population exposed by adolescence. [8] A systemic
host response to periodontal microbiota is manifested through the presence of
antibacterial antibodies in the serum [9] as well as by elevated inflammatory
cytokines. [10]
Epidemiological evidence supports an association between the level of serum
antibodies to periodontal pathogens and stroke, [11–13] and accelerated aortic
atherogenesis. [14] High levels of colonization by specific periodontal pathogens
are associated with increased carotid artery intimal-medial thickness. [15] Risk
factors for stroke and dementia have a similar systemic inflammatory profile to
periodontitis [16] and suggest a final common pathway of atherogenesis related to
systemic inflammation. [16]
Poor dental status, a late-life marker of the cumulative effects of oral
inflammatory pathologic conditions including periodontitis, is associated with
prevalent cognitive impairment and incident dementia. [17] We previously
identified a cross-sectional association between high serum IgG to a common
periodontal pathogen, Porphyromonas gingivalis, and poor cognitive test
performance among people aged .60 years in the Third National Health and
Nutrition Examination Survey (NHANES-III). [18] Another group reported that
TNF-a levels in combination with three periodontal IgG titers could discriminate
between patients with Alzheimer disease (AD) and cognitively normal individuals.
[19] Studies exploring associations of serologic markers of periodontitis and
cognition have been limited to cross-sectional analyses and neuropsychological
measurements. [17] A growing body of evidence associating periodontitis with
stroke [20] and cognitive impairment [17] justifies further investigation of a
possible association between poor oral health and incident dementia.
Periodontitis and Alzheimer Disease
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In this study, pre-morbid levels of serum IgG antibodies to selected periodontal
microbiota were explored for possible association with risk for incident AD. We
hypothesized that serologic markers of periodontitis can serve as predictors of
incident cognitive impairment among older adults, and tested this hypothesis in a




WHICAP has longitudinally followed a multiethnic elderly community popula-
tion in northern Manhattan with serial neuropsychological assessments repeated
every 18–24 months. Study design, criteria for diagnosis of AD, and vascular risk
factor definitions have been described elsewhere. [21, 22] The subset included in
the present analyses consisted of WHICAP participants enrolled in 1999–2000
with no prevalent cognitive impairment or dementia at the time of phlebotomy
and $1 follow-up visits thereafter. Archived sera were available from
phlebotomized subjects at the first follow-up visit which occurred in 2001 for
most participants; presence of individual vascular risk factors was determined at
the first visit.
Study design
The present study has a case-cohort design, comparing individuals with incident
probable Alzheimer disease with controls without incident dementia through the
last available follow-up, matched by race-ethnicity. This design is advantageous
for the purposes of an exploratory study because of its cost-efficiency, [23] but
may be prone to sampling bias, and thus warrants conservative statistical analyses.
[23, 24]
Determination of cases and controls
Individuals to be included in this study were selected in October 2010. Cases were
identified as persons without prevalent AD at the time of phlebotomy who were
subsequently determined clinically to have AD during follow-up. [21] Controls
were identified based on absence of clinical dementia at the time of the last
available follow-up. Cases and controls were proportionately matched based on
race-ethnicity, given the known impact of race-ethnicity on antibody titers, [25]
rates of dementia, [26] and cognitive decline. [27] Control participants were
stratified by race-ethnicity and then randomly selected for inclusion.
Thus, the sample included 135 incident AD cases and 134 controls, of whom
110 cases and 109 controls had available serum. Controls comprised approxi-
mately 10% of the overall control sample; for these analyses, the sampling fraction
was equal to 1 for cases and 1/10 for controls.
Periodontitis and Alzheimer Disease
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Assessment of serum IgG antibody levels
Serum IgG antibody levels to periodontal bacteria were determined by means of
checkerboard immunoblotting [28] as previously described. [29] Assessments
were carried out for bacteria with known positive or negative associations with
clinical periodontitis: [9] Porphyromonas gingivalis (strain FDC381), Tannerella
forsythia (ATCC43037), Actinobacillus actinomycetemcomitans (FDCY4),
Treponema denticola (OMGS3271), Campylobacter rectus (ATCC33238),
Eubacterium nodatum (OMGS3356), and Actinomyces naeslundii genospecies 2
(ATCC15987).
Periodontal antibody threshold levels
Antibody threshold levels were used as a proxy for exposure to common
periodontal pathogens, based on the strong associations with clinical periodontitis
identified by our group in NHANES-III. [9] At-risk individuals were defined
using two a priori approaches: a) those exceeding single antibody thresholds
distinguishing clinical periodontitis from healthy periodontal conditions [9] and
b) those in the highest serum antibody level quintile. In NHANES-III, the clinical
threshold values corresponded to the 90th percentile titer of individuals free of
periodontitis according to the definitions by the Centers for Disease Control and
Prevention/American Academy of Periodontology (CDC/AAP). [30] Because two
sets of clinical thresholds were identified for the two NHANES-III phases, the
lower of the two were used in the present analyses.
Statistical analyses
Descriptive analyses used t-tests for comparing means of continuous variables,
and x2 tests for comparing categorical variables. Multivariable Cox proportional-
hazards regression models were used to examine individual associations between
each of the seven antibody thresholds and incident AD. Time-to-event was
defined as duration from phlebotomy to time of AD diagnosis. To minimize
small-sample bias, conservative methods suited for case-cohort analyses were
used, including derivation of an ‘‘exact’’ pseudolikelihood estimator for the point
estimate, and robust variance estimation for derivation of the 95% confidence
interval for each association. [23, 24, 31] Controls were weighted by the inverse of
the sampling fraction. The strength of the association between high antibody titers
and dementia status was explored before and after adjusting for selected
covariates, including age at enrollment, sex and education, as well as known
vascular risk factors including hypertension, diabetes mellitus (DM), hyperlipi-
demia, stroke history, heart disease, tobacco abuse, and APOE e4 carrier status.
Based on power calculations, 100 matched pairs afforded sufficient power to
identify $38.5 ng/ml difference in mean antibody levels between AD and
controls. All analyses were performed on an anonymized and de-identified data
set using SAS v. 9.3. The Institutional Review Board of Columbia University
Medical Center approved this proposal.
Periodontitis and Alzheimer Disease
PLOS ONE | DOI:10.1371/journal.pone.0114959 December 18, 2014 4 / 14
Results
Cases were older at enrollment, had shorter follow-up time (person-years follow-
up: cases54.4 years [SD52.5], controls55.5 years [SD52.5], p50.001), were less
educated, and were more likely to have a history of prior stroke (Table 1). In
comparison to the overall WHICAP cohort, the participants in the case-cohort
study were similar in most regards, although differed in race-ethnic composition,
education history, and hypertension prevalence. Percentiles of antibody levels,
relative to previously published antibody thresholds for clinical periodontitis, [9]
are listed in Table 2. High antibody levels to C. rectus were found in 69% of the
participants, followed by 63% to T. forsythia, 53% to T. denticola, 23% to P.
gingivalis, 19% to E. nodatum, 11% to A. actinomycetemcomitans and 10% to A.
naeslundii. The proportions did not differ between cases and controls (Table 2).
Participants with elevated A. naeslundii serum IgG (.640 ng/ml) had a
consistently higher risk for incident AD (Table 3), ranging from 80%–100%, with
similar yet less precise estimates emerging from more conservative statistical
analyses. This finding remained robust in the fully adjusted Cox model, which
included age, sociodemographic variables, vascular risk factors, APOE status, and
histories of DM, stroke, tobacco abuse, and hypertension (hazard ratio (HR)52.0,
95% CI: 1.1–3.8). In addition, in a fully adjusted model, high antibody levels to E.
nodatum (.1755 ng/ml) approached statistical significance with a decreased risk
of incident AD (HR50.7, 95% CI: 0.4–1.2, p50.19). Fully adjusted survival curves
are provided for each of these analyses in S1 and S2 Figures. Next, when high
titers to both A. naeslundii and E. nodatum were included into similar models
(Table 4), a greater risk of incident AD was observed in the presence of high A.
naeslundii levels (HR53.1, 95% CI: 1.5–6.4), but a lesser risk in the presence of
high E. nodatum levels (HR50.5, 95% CI: 0.2–0.9) in the fully adjusted model.
Neither antibody demonstrated evidence of being an effect modifier of the other
in this relationship.
When considering the highest quintile levels for A. naeslundii (.380.9 ng/ml)
and E. nodatum (.1609.6 ng/ml) individually, no significant association with risk
of incident AD was identified in these models (Table 5). However, when
including both antibody highest quintiles simultaneously, a similar association
was found in the fully adjusted models (A. naeslundii HR51.9, 95% CI 1.0–3.5
and E. nodatum HR50.5, 95% CI 0.2–0.9), as when using the individual
thresholds (Table 4).
Discussion
In this community-based, multiethnic cohort of elders, an increased risk of
incident AD was observed among participants with high serum A. naeslundii IgG
antibody, and this finding was further strengthened when high E. nodatum levels
were also included in the model. To our knowledge, this is the first longitudinal
study to identify an association between these serological markers of periodontal
infection and incident AD.
Periodontitis and Alzheimer Disease
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There are several plausible mechanisms relating periodontal infections to
impaired cognition: [17] First, periodontitis could affect risk of cognitive
impairment on the basis of stroke and accelerated atherogenesis. [32, 33] A second
possibility is that periodontitis could be related to cognition via subclinical
cerebrovascular damage in those without stroke. Similar to DM, hypertension,
and smoking, [34] periodontitis is associated with impaired arterial endothelial
function [35] which, in turn, has been associated with cerebral white matter






(N51957) p-value* Controls (n5109) Cases (n5110) p-value**
Age at enrollment, years
(SD)
75.6 (6.9) 76.2 (6.5) 0.14 72.3 (4.6) 78.9 (7.2) ,0.001
Women, n (%) 148 (67.6) 1150 (66.2) 0.68 73 (67.0) 75 (68.2) 0.85
Hispanic, n (%) 105 (47.9) 575 (33.1) ,0.001 52 (47.7) 53 (48.2) 0.94
Non-Hispanic Black, n (%) 58 (26.5) 570 (32.8) — 30 (27.5) 28 (25.5) 0.73
Education, years (SD) 9.9 (5.3) 10.7 (4.7) 0.02 11.9 (4.6) 7.8 (5.1) ,0.001
APOE- 4, n (%) 54 (25.2) 398 (26.8) 0.50 28 (26.4) 26 (24.1) 0.69
Diabetes, n (%) 41 (18.7) 330 (19.2) 0.87 17 (15.6) 24 (21.8) 0.24
Hypertension, n (%) 125 (57.1) 1172 (68.1) 0.001 62 (56.9) 63 (57.3) 0.95
Stroke history, n (%) 20 (9.1) 184 (10.7) 0.48 3 (2.8) 17 (15.5) 0.001
Current Smoker, n (%) 20 (9.6) 151 (9.5) 0.85 12 (11.5) 8 (7.6) 0.34
P-values based on t-test for continuous variables, and on chi-square for categorical variables.
*Case-cohort study v. complete WHICAP cohort.
**Cases v. controls within the case-cohort study.
doi:10.1371/journal.pone.0114959.t001
Table 2. Distribution of serum IgG antibody levels to selected periodontal species.




Study Subjects Exceeding CDC/AAP
Threshold* n (%)
Percentile









A naeslundii 0 0 29.8 97.2 163.0 336.9 380.9 13942.2 640 22 (10.0) 10 (9.2) 12 (10.9) 0.67
E. nodatum 86.6 122.1 318.4 489.0 627.8 1204.1 1609.6 75725.0 1755 42 (19.1) 23 (21.1) 19 (17.3) 0.47
P. gingivalis 52.2 83.6 200.3 307.6 402.7 672.1 865.3 15398.8 713 50 (22.8) 25 (22.9) 25 (22.7) 0.97
T. forsythia 32.3 56.7 140.5 194.2 266.1 409.3 482.7 9475.6 128 137 (62.6) 72 (66.1) 65 (59.1) 0.29
T. denticola 31.1 51.3 105.6 160.2 225.6 353.1 431.5 8317.6 136 116 (53.0) 62 (56.9) 54 (49.1) 0.25
C. rectus 38.4 61.2 156.7 269.6 356.8 667.8 829.5 16419.4 112 150 (68.5) 78 (71.6) 72 (65.5) 0.33
A.
actinomycetemcomitans
64.7 89.4 186.4 253.4 336.5 507.4 558.6 9284.9 730 25 (11.4) 10 (9.2) 15 (13.6) 0.30
*Thresholds are drawn from a study of NHANES-III subjects [9]; above each individual periodontal pathogen level, the accuracy of a serology-based
diagnostic test to detect moderate-severe periodontitis according to the CDC/AAP definition is maximized. [30].
doi:10.1371/journal.pone.0114959.t002
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hyperintensities, [36] vascular dementia, and AD. [37, 38] Alternatively, period-
ontitis could be associated with dementia risk through systemic inflammation, a
process that has been hypothesized to directly influence expression of
neurodegenerative disorders such as AD. [39] Other clinical measures of oral
Table 3. Regression models: Association of high clinical threshold [9] levels of serum IgG to selected periodontal species and incident AD.
Periodontal pathogen Cox proportional Hazards Regression Model


































































































































Model 1: bivariate association with single periodontal antibody.
Model 2: controlled for age at phlebotomy (baseline).
Model 3: Model 2, also controlled for APOE status, gender, and education.
Model 4: Model 3, also controlled for hypertension, smoking, stroke, and diabetes mellitus.
*Models shown using pseudolikelihood estimator, robust variance estimator, and weight of cases (1), controls (10) [most conservative method].
Models highlighted in bold indicate p,0.05. HR: Hazard ratio.
doi:10.1371/journal.pone.0114959.t003
Table 4. Regression models: Association of high levels of serum IgG to A. naeslundii and E. nodatum and incident AD.
Periodontal
pathogen Cox proportional Hazards Regression Model Pseudolikelihood estimator with robust variance estimator*

















A. naeslundii 1.8 (0.9–3.4) 2.6 (1.3–5.1) 2.6 (1.3–5.3) 3.1 (1.5–6.4) 2.3 (1.2–4.1) 2.6 (1.4–4.7) 2.4 (1.2–5.2) 3.1 (1.4–6.5)
E. nodatum 0.9 (0.6–1.7) 0.6 (0.4–1.1) 0.5 (0.6–1.0) 0.5 (0.2–0.9) 0.6 (0.3–1.0) 0.5 (0.3–0.9) 0.4 (0.2–1.0) 0.4 (0.2–0.9)
Using 80th percentiles Using 80th percentiles
A. naeslundii 1.2 (0.7–2.0) 1.5 (0.9–2.5) 1.9 (1.1–3.5) 1.9 (1.0–3.5) 1.5 (0.8–2.7) 1.4 (0.8–2.5) 1.9 (1.0–3.8) 2.0 (1.0–4.0)
E. nodatum 1.0 (0.6–1.7) 0.7 (0.4–1.2) 0.5 (0.3–1.0) 0.5 (0.2–0.9) 0.6 (0.3–0.9) 0.6 (0.3–1.1) 0.4 (0.2–0.9) 0.4 (0.1–0.9)
Model 1: bivariate association with both antibodies included in the model.
Model 2: controlled for age at phlebotomy (baseline).
Model 3: Model 2, also controlled for APOE status, gender, and education.
Model 4: Model 3, also controlled for hypertension, smoking, stroke, and diabetes.
*Models shown using pseudolikelihood estimator, robust variance estimator, and weight of cases (1), controls (10) [most conservative method].
Models highlighted in bold indicate p,0.05. HR: Hazard ratio.
doi:10.1371/journal.pone.0114959.t004
Periodontitis and Alzheimer Disease
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health including tooth loss are associated with incident dementia and suggest a
possible effect modification with education and APOE. [17]
The primary finding of the study is that high serum A. naeslundii IgG is
associated with increased risk of incident AD. A. naeslundii is a gram positive rod
associated with early dental plaque formation, [40] gingivitis, [41] and dental
caries. [42] The relationship between serologic evidence of A. naeslundii host
response and general health outcomes has not been explored to the same extent as
with established periodontal pathogens such as P. gingivalis that has been
implicated in atherogenesis. [14, 43] Although high levels of A. naeslundii
antibodies are associated with periodontal health [9], plaque biofilms include high
proportions of A. naeslundii. [44] A. naeslundii, and specifically the peptidoglycan
from its cell wall, likely has a strongly pathogenic role in osteoclast activation and
alveolar bone loss similar to gram negative periodontal organisms such as P.
gingivalis, including elevation of IL-1b, IL-6, and TNF-a mRNA. [45]
Multispecies microbial biofilms including A. naeslundii can elicit strong
expression of several cytokines and chemokines in oral epithelial cells, including
IL-1a, IL-6, TGFa, IL-8, fractalkine, and interferon gamma-induced protein (IP-
10). [46]
Additionally, high serum E. nodatum IgG levels were associated with lower AD
risk in the most conservative regression models. E. nodatum is a gram positive,
anaerobic rod that has been implicated in periodontitis. [47] Although its role in
oral disease pathogenesis is uncertain, high levels of E. nodatum oral colonization
Table 5. Regression models: Association of high levels (80th percentile) of serum IgG to selected periodontal species and incident AD.
Periodontal Pathogen Cox proportional Hazards Regression Model


































































































































Model 1: bivariate association with single periodontal antibody.
Model 2: controlled for age at phlebotomy (baseline).
Model 3: Model 2, also controlled for APOE status, gender, and education.
Model 4: Model 3, also controlled for hypertension, smoking, stroke, and diabetes.
*Models shown using pseudolikelihood estimator, robust variance estimator, and weight of cases (1), controls (10) [most conservative method]; HR: Hazard
ratio.
doi:10.1371/journal.pone.0114959.t005
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are associated with generalized aggressive periodontitis among younger indivi-
duals [48] as well as more broadly, with chronic periodontitis in adults. [49].
However, high serum E. nodatum IgG was associated with lower risk for clinical
periodontitis in NHANES-III. [9] Taken together, these findings underscore the
complex role of host immune response in periodontitis, and possibly AD, and
these relationships warrant further exploration.
Our group previously reported that high antibody levels to P. gingivalis were
cross-sectionally associated with poor cognitive test performance among patients
aged .60 years in NHANES-III. [18] In the same cohort, clinical markers of
periodontitis (gingival bleeding, loss of periodontal attachment, and tooth loss)
were associated with impaired attention among 20–59 year olds, [50] but these
same clinical measures of periodontitis were not associated with impaired recall
among those aged 70 years and older. [50] The cause for the discrepancy between
serological and clinical markers of periodontitis with poor cognition is uncertain
but could relate in part to the equivocal relationship between serum antibodies to
periodontal microbiota and clinical periodontal status, the imprecise clinical
periodontal measurements in NHANES-III, [51, 52] or residual confounding.
Cross-sectional analyses do not allow for inferences regarding directionality of the
association of cognition and dental health.
The clinical significance of a high antibody response to specific periodontal
microbiota is uncertain. As previously demonstrated, [25] antibody responses to
periodontal bacteria are influenced by multiple factors beyond the clinical
periodontal status, including race/ethnicity, smoking habits and likely also
unmeasured health behaviors. Host antibody responses to periodontal bacteria
could also reflect a co-infection with other microbiota with shared antigenic
epitopes, many of which are not readily cultivable. [53] Serum antibody levels to
periodontal pathogens remain relatively stable after periodontal therapy, and are
markedly lower in periodontally healthy subjects, suggesting antibody levels
signify the cumulative exposure to oral pathogens and can help discriminate
between subjects with high and low susceptibility to severe disease. [54]
Interestingly, the observed relationships between high levels of IgG to A.
naeslundii and E. nodatum and incident AD were strengthened when these
antibody responses were explored jointly in regression models. Taken together,
these findings suggest the host response to these two periodontal species, although
primarily targeted towards control of the localized periodontal infection, may
nevertheless stimulate a systemic inflammatory cascade, and support a hypothesis
of mediation of incident AD risk through systemic host inflammatory responses.
Since data on clinical periodontal status and inflammatory markers such as CRP
were not available in this study, a potential interaction between clinical
periodontitis and systemic antibody responses cannot be determined.
Several additional limitations and potential strengths of the present study are
acknowledged. Measurable socioeconomic covariates provide a restricted scope of
lifelong socioeconomic status, and could lead, at least in part, to residual
confounding. However, the influence of socioeconomic differences was likely
diminished by matching cases and controls on race-ethnicity. Additionally,
Periodontitis and Alzheimer Disease
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adjusting for chronological age alone might not capture residual confounding due
to age-related illnesses that are variably distributed between people of similar ages.
Although analyses were limited to the study of antibodies to seven periodontal
bacteria, these were preselected on the basis of their documented association with
clinical periodontal status [9] and thus facilitated a more hypothesis-driven,
rather than exploratory approach. Likewise, we consider it a strength of the study
that the used threshold values for high serum high IgG levels were based on
findings from an independent cohort which identified associations with clinically
assessed periodontitis. [9] No significant associations between individual
antibacterial antibody levels and incident AD were identified when using the a
priori cutoff of the 80th percentile, which as shown in Table 2 differed by up to 7-
fold compared with previously established clinical status-associated thresholds. In
some regards, this suggests that clinical thresholds may be more important to
consider than more conventional quintile or quartile cut-off points. We did not
pursue analyses using a sum of high antibody thresholds as in previous work [55]
for several reasons: 1) this is not an established practice in the periodontal
literature linking clinical and serological evidence of disease, 2) some of the
antibodies included in the analyses are associated with periodontal health, and 3)
the sample size was insufficient for such analyses. Some information could
potentially be lost when grouping individual subjects into antibody categories
rather than analyzing antibody values as continuous variables. However, the
antibody level values were not normally distributed, nor could a normal
distribution be achieved through conventional transformations (i.e., log-based or
quadratic) given that a substantial number of individuals had no detectable levels
for several antibodies, particularly A. naeslundii.
The possibility of a small-sample bias is also recognized. However, we used
previously described methodology [23, 24, 31] to limit this bias, and the case-
cohort sample reasonably approximated the characteristics of the overall study
cohort. For example, in the present sample, older age and lower educational
attainment conferred risk for incident AD in a similar manner as in the overall
WHICAP cohort (data not shown). Although the associations of single antibody
analyses were less precise, the findings are commensurate with the Cox-
proportional hazards regression models. Importantly, simultaneous inclusion of
both A. naeslundii and E. nodatum in the model resulted in nearly identical
findings using both statistical methods. Moreover, the prevalence of high antibody
levels was similar to the prevalence of other risk factors for dementia including
DM [56] and stroke. [57] Given the small sample size of this study, adjustment for
inflation of Type 1 error was not feasible and remains a limitation, given that
several antibodies were jointly entered in the regression models. Furthermore, it is
well established that periodontitis is not a mono-infection but rather a
polybacterial disruption of host homeostasis. Consequently, antibody levels to
several periodontal microbiota are interrelated, as also demonstrated by the
correlation matrix in Table S1. Finally, persons with baseline mild cognitive
impairment were not excluded and thus the possibility of reverse causation, i.e.,
Periodontitis and Alzheimer Disease
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that cognitive impairment may have affected the antibody levels to periodontal
microbiota, cannot be ruled out.
The levels of serum antibodies to periodontal bacteria alone do not capture the
complex interplay between bacterial infection and host response in the context of
periodontitis, and as suggested here, possibly AD. The present findings are based
on a limited sample, and their external validity needs to be confirmed in
independent cohorts. Notably, since the development of this study, serum
antibodies to other periodontal organisms not included in the panel investigated
here have also been identified as potential risk markers for AD and mild cognitive
impairment. [58] As recently reviewed elsewhere, [17] further multimodal
exploration of the role of periodontal infections, other oral health markers, and
the systemic host response may elucidate a novel potential causal pathway for
cognitive impairment among the elderly.
Supporting Information
S1 Figure. Cox-proportional hazards regression of dementia-free survival of the
association with high A. naeslundii antibody levels above a clinically defined
threshold [9] (solid line) and those with low A. naeslundii antibody levels (dotted
line) in a fully adjusted model (controlling for age at phlebotomy, APOE status,
gender, education, hypertension, smoking, stroke, and diabetes).
doi:10.1371/journal.pone.0114959.s001 (DOCX)
S2 Figure. Cox-proportional hazards regression of dementia-free survival of the
association with high E. nodatum antibody levels above a clinically defined
threshold [9] (solid line) and those with low E. nodatum antibody levels (dotted
line) in a fully adjusted model (controlling for age at phlebotomy, APOE status,
gender, education, hypertension, smoking, stroke, and diabetes).
doi:10.1371/journal.pone.0114959.s002 (DOCX)
S1 Table. Aa: A. actinomycetemcomitans, Pg: P. gingivalis, Tf: T. forsythia, Td: T.
denticola, Cr: C. rectus, En: E. nodatum, and An: A. naeslundii.
doi:10.1371/journal.pone.0114959.s003 (DOCX)
S1 Data. This dataset provides the periodontal antibody levels (ng/ml) for all 219
participants included in this study.
doi:10.1371/journal.pone.0114959.s004 (XLSX)
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